China’s Burning Rock, Sciwind close venture rounds

Burning Rock Biotech (Guangzhou, China) closed a RMB850 million ($125.4 million) series C round financing and Sciwind Biosciences Co. Ltd. (Hangzhou, China) raised about RMB200 million ($29.5 million) in a series A round.

GIC led Burning Rock’s financing, with participation by Lyfe Capital, CMB International Capital, Lilly Asia Ventures, Sequoia Capital China and T&Brothers Capital...